// App-Quantinova.ai

EV0753 : New insights in the pharmacotherapy of psychosis: The example of Parkinson's disease psychosis

Researchers

Presenter

  • A.Fontaine

Principal Investigators

  • G.Radu

Medical Centers

  • University Lille, CHU Lille, Department of Psychiatry, Lille, France

  • Memorial University, Psychiatry, St John's, Canada

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Serotonin 2A receptor

Drug/Treatment

  • Pimavanserin

  • Risperidone

  • Olanzapine

  • Quetiapine

  • Clozapine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved